Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
NCT04901325
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Pyoderma Gangrenosum
Skin Diseases
Wound Heal
Pyoderma
Skin Ulcer
Interventions
DRUG:
Baricitinib
Sponsor
Oregon Health and Science University